Aditya Chandorkar

Aditya Chandorkar, MBBS, serves as Assistant Professor in the Department of Medicine at the University of Minnesota, specializing within the Division of Infectious Diseases and International Medicine. His clinical and research focus centers on complex infectious disease management in immunocompromised populations, particularly solid organ and hematopoietic cell transplant recipients, with expertise spanning antimicrobial stewardship, viral pathogen management, and multidrug-resistant infections.

Dr. Chandorkar's research program demonstrates deep specialization in transplant infectious diseases, with extensive work on viral pathogens including norovirus, adenovirus, cytomegalovirus, and SARS-CoV-2 in transplant settings. His scholarship prominently features antimicrobial stewardship innovations, particularly telehealth-based programs extending academic expertise to community hospitals. Additional critical areas include antimicrobial resistance management for carbapenem-resistant organisms, immune monitoring for CMV prevention, and pandemic response strategies for transplant programs.

Analysis of his publication record (2020-2025) reveals consistent emphasis on optimizing infection management in vulnerable transplant populations through evidence-based interventions. His work demonstrates methodological diversity across multicenter cohort studies, single-center experiences, and guideline implementation analyses. Key thematic threads include viral kinetics in immunocompromised hosts, diagnostic challenges in co-infections, and practical antimicrobial stewardship models applicable to resource-limited settings.

Scientific Awards: No awards were documented in the available source material.

Advising and Grants: Information regarding student mentorship, research grants, or funded projects was not present in the provided text. His collaborative publication patterns suggest engagement with multidisciplinary teams across academic and community healthcare settings.

Labs and Teams: Dr. Chandorkar operates within the University of Minnesota's Division of Infectious Diseases and International Medicine, with documented partnerships between academic medical centers and community hospitals for tele-antimicrobial stewardship initiatives. His research involves cross-institutional collaborations with infectious disease specialists, transplant surgeons, pharmacists, and laboratory scientists focused on improving outcomes for immunocompromised patients.